Come Be an Angel: Angel Investing 101

HAYVN Coworking

Have you ever thought that you’d like to help early stage companies grow but you don’t know enough about the process? Or that you’d like...

WIB-CT First Annual Golf Event & Chapter Networking

Lyman Golf Club 70 Lyman Rd., Middlefield

Come join us at the ‘tee’ for an afternoon of golf and networking. We start the afternoon with a golf clinic by Lyman’s PGA and...

ABCT 2023 Cohort Information Session

Join us at this information session to learn first hand about the ABCT 2023 programs. Ask your questions in a virtual format. Hear about the...

​It’s been one year since the passage of the IRA. The Centers for Medicare & Medicaid Services has moved forward implementing the law’s various provisions, including the new Medicare negotiation program and the redesign of the Medicare Part D benefit. Learn the latest developments from our panel of experts, including how the IRA is impacting biopharmaceutical companies today. Panelists will delve into other important issues beyond the IRA, including new developments in Medicaid, 340B, and the emergence of Prescription Drug Affordability Boards in a number of states.

John Murphy, Chief Policy Officer, BIO

Crystal Kuntz, SVP, Health Policy & Reimbursement, BIO
Erin Hertzog, Partner, Foley Hoag LLP
Jim Meyers, Senior Advisor, BCG